The Disease Detective: Finding the Right Problem to Solve

In the autumn of 1908, a young Russian physician named Ernest Oppert arrived at a hospital in Berlin with a troubling observation. In the wards dedicated to treating diabetes—a disease that turned patients into living ghosts, their bodies wasting away as sugar flooded their blood and urine—he noticed something peculiar. Certain patients, particularly those from poor neighborhoods, seemed to fare better than their wealthy counterparts. The wealthy patients, who could afford to eat as much rich food as they wished, died faster. The poor patients, who subsisted on limited diets of simple foods, lived longer. It was an observation that would take medicine nearly a century to fully understand, and it would eventually lead to one of the most important drug discoveries in history.

This chapter tells the story of how that observation, combined with decades of painstaking research, led to our modern understanding of diabetes and, more importantly, to a fundamental truth about all drug discovery: before we can cure a disease, we must understand it. Not just superficially, not just enough to treat its symptoms, but deeply enough to know why it happens in the first place. The journey from Oppert's ward in Berlin to the metformin pills found in medicine cabinets worldwide today is a journey through the very heart of what it means to be a disease detective.

The Mystery of Sweet Urine

To appreciate the magnitude of the challenge facing early diabetes researchers, we must first understand the disease they were trying to understand. Diabetes mellitus—what we today simply call diabetes—is not a single disease but a group of metabolic disorders characterized by chronically elevated blood glucose levels. Left untreated, this elevated glucose damages nearly every organ system in the body, leading to blindness, kidney failure, nerve damage, heart disease, and ultimately death.

The word "mellitus" comes from the Latin word for honey, a reference to the sweet taste of urine from diabetic patients. This sweetness was first documented in ancient Egypt, where physicians noted that ants were attracted to the urine of certain patients. In the first century CE, the Greek physician Aretaeus of Cappadocia gave the disease its name—"diabetes," meaning "a passing through," a reference to the characteristic excessive urination—and described its devastating effects with remarkable accuracy: "The patients never stop making water; the urine keeps flowing in an uninterrupted stream. The patients are dulled and racked with a thirst that is never quenched."

For thousands of years, physicians could do little more than observe these symptoms and document the disease's progression. They had no understanding of what caused the body to lose its ability to regulate blood sugar, no insight into the mechanisms at work, and therefore no hope of developing treatments that addressed the root cause. All they could do was watch their patients die, sometimes slowly, sometimes quickly, but always inevitably.

The first major breakthrough came in 1869, when a young German medical student named Paul Langerhans discovered a previously unknown structure in the pancreas. Through his microscope, he saw small clusters of cells scattered throughout the pancreas that were distinctly different from the surrounding tissue. Langerhans had no idea what these cells did—he hypothesized they might be some form of connective tissue—but he documented them carefully, creating detailed drawings that would later prove invaluable. These clusters of cells became known as the "islets of Langerhans," and they would eventually be recognized as the master regulators of blood sugar.

Nearly two decades passed before another scientist made the critical connection. In 1889, German physiologist Oskar Minkowski and his colleague Joseph von Mering made a startling discovery while investigating the role of the pancreas in digestion. They removed the pancreas from a dog to study how it aided in fat digestion. Within days, the dog developed all the classic symptoms of diabetes—it began urinating excessively, its urine was sweet, and it grew increasingly weak. When the researchers tested its urine, they found high levels of glucose. The dog had become diabetic.

This was a pivotal moment. Minkowski realized that the pancreas, which he had always assumed was involved only in digestion, must somehow regulate blood sugar. Something in the pancreas—the same tissue that Langerhans had documented—was preventing diabetes. When the pancreas was removed, that protective factor disappeared.

The hunt was on. Scientists around the world began searching for this mysterious substance, this "something" in the pancreas that prevented diabetes. But the search would take more than thirty years, and it would require not just biochemical expertise but also a kind of detective work that would establish the template for modern drug discovery.

The Birth of Disease Etiology

To understand the ultimate success of diabetes research, we must first appreciate a fundamental shift in how physicians thought about disease. In the early twentieth century, medicine was undergoing a revolution. For centuries, diseases had been classified and treated based on their symptoms—what the patient experienced, what the physician observed. Tuberculosis meant a persistent cough and bloody sputum. Syphilis meant characteristic rashes and eventual madness. Diabetes meant excessive urination and sweet urine.

This approach, while practical, had a critical flaw: it treated symptoms rather than causes. Two patients with the same symptoms might have entirely different underlying conditions. Conversely, a single disease might manifest very differently in different patients. Physicians were working in the dark, unable to see the mechanisms driving the disease, only its visible effects.

The concept of disease etiology—understanding not just what goes wrong but why it goes wrong—represented a new way of thinking. Etiology, from the Greek words for "cause" and "study," asks fundamental questions: What triggers this disease? What is happening at the cellular and molecular level? Why does one person develop a condition while another, exposed to the same factors, does not?

This shift from symptom-based to mechanism-based thinking transformed medicine. Instead of asking "How do we stop excessive urination in diabetic patients?" physicians began asking "What in the body normally prevents excessive urination, and why does that mechanism fail?" Instead of asking "How do we lower blood sugar?" they asked "What normally regulates blood sugar, and how can we restore that regulation?"

The implications for drug discovery were profound. When you understand the mechanism of a disease, you can identify specific points where intervention might be possible. You can ask: What molecules are involved? Where in the body are they active? What happens if we increase or decrease their activity? Can we create a drug that specifically targets this mechanism without causing unwanted effects elsewhere?

This is the essence of modern drug discovery: find the right target, the specific molecular mechanism whose modulation will treat or cure the disease, then develop a molecule that can modulate that target. But finding the right target requires first understanding the disease—truly understanding it, at its most fundamental level. This is the work of the disease detective.

Frederick Banting's Grandfather Experiment

The breakthrough in diabetes research came in the summer of 1921, and it came from an unlikely source: a young Canadian surgeon named Frederick Banting, who had little experience with metabolic research and almost no background in biochemistry. Banting was not a rising star in academic medicine; he was a struggling physician who had been forced to take a part-time teaching job at the University of Toronto because he could not attract enough patients to make a living. Yet he had an idea that wo